Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) has sold its five U.S. wellness clinics to Stella for US$3.53 million, marking a strategic shift towards an asset-light business model. The deal includes a data-sharing partnership to develop AI-based clinic management solutions for mental health providers.
The transaction terms include US$2.08 million paid at closing, US$750,000 in monthly installments throughout 2025, and potential earn-out compensation of up to US$0.7 million. Numinus will leverage its experience of serving 50,000 unique individuals and processing 250,000 insurance-reimbursed claims to develop solutions for an estimated market of 200,000 U.S. mental health care providers.
The company's Cedar Clinical Research has conducted 24 clinical trials with nearly 1,100 patients, while its practitioner training program has attracted almost 2,000 learners from 18 countries since May 2024.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) ha venduto le sue cinque cliniche di benessere negli Stati Uniti a Stella per 3,53 milioni di dollari, segnando un cambiamento strategico verso un modello di business a basso impatto patrimoniale. L'accordo include una partnership per la condivisione dei dati per sviluppare soluzioni di gestione clinica basate su AI per i fornitori di salute mentale.
I termini della transazione prevedono 2,08 milioni di dollari pagati al momento della chiusura, 750.000 dollari in rate mensili fino alla fine del 2025, e un potenziale compenso accessorio fino a 700.000 dollari. Numinus sfrutterà la sua esperienza nel servire 50.000 individui unici e nel gestire 250.000 richiesta di rimborso assicurativo per sviluppare soluzioni per un mercato stimato di 200.000 fornitori di servizi di salute mentale negli Stati Uniti.
La divisione Cedar Clinical Research dell'azienda ha condotto 24 studi clinici con quasi 1.100 pazienti, mentre il suo programma di formazione per i professionisti ha attratto quasi 2.000 studenti provenienti da 18 paesi dal maggio 2024.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) ha vendido sus cinco clínicas de bienestar en Estados Unidos a Stella por 3.53 millones de dólares, marcando un cambio estratégico hacia un modelo de negocio ligero en activos. El acuerdo incluye una asociación de intercambio de datos para desarrollar soluciones de gestión clínica basadas en IA para proveedores de salud mental.
Los términos de la transacción incluyen 2.08 millones de dólares pagados al cierre, 750.000 dólares en pagos mensuales hasta 2025, y una posible compensación de até 700.000 dólares. Numinus aprovechará su experiencia en atender a 50,000 individuos únicos y procesar 250,000 reclamaciones reembolsadas por seguros para desarrollar soluciones para un mercado estimado de 200,000 proveedores de salud mental en Estados Unidos.
La investigación clínica de la compañía Cedar ha realizado 24 ensayos clínicos con casi 1,100 pacientes, mientras que su programa de formación para profesionales ha atraído a casi 2,000 estudiantes de 18 países desde mayo de 2024.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF)가 미국 내 다섯 개의 웰니스 클리닉을 Stella에 353만 달러에 매각하며 자산 경량 사업 모델로의 전략적 전환을 알렸습니다. 이번 거래는 정신 건강 제공자를 위한 AI 기반 클리닉 관리 솔루션 개발을 위해 데이터 공유 파트너십을 포함합니다.
거래 조건에는 마감 시 208만 달러가 지급되며, 2025년까지 월별 할부로 75만 달러가 지급되고, 최대 70만 달러의 추가 보상이 포함됩니다. Numinus는 5만 명의 독특한 개인에게 서비스를 제공하고 25만 건의 보험 환급 청구를 처리한 경험을 활용하여 미국의 약 20만 개 정신 건강 제공자를 대상으로 솔루션을 개발할 예정입니다.
회사의 Cedar Clinical Research는 거의 1,100명의 환자를 대상으로 24개의 임상 시험을 수행했으며, 2024년 5월 이후 18개국에서 거의 2,000명의 수강생이 참여한 전문가 교육 프로그램이 있습니다.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) a vendu ses cinq cliniques de bien-être aux États-Unis à Stella pour 3,53 millions de dollars, marquant un changement stratégique vers un modèle d'affaires léger en actifs. L'accord comprend un partenariat pour le partage des données afin de développer des solutions de gestion des cliniques basées sur l'IA pour les prestataires de santé mentale.
Les conditions de la transaction incluent 2,08 millions de dollars payés à la clôture, 750 000 dollars en versements mensuels jusqu'en 2025, et une compensation actuelle potentielle allant jusqu'à 700 000 dollars. Numinus mettra à profit son expérience avec 50 000 individus uniques et 250 000 demandes d'indemnisation d'assurance pour développer des solutions pour un marché estimé à 200 000 prestataires de soins de santé mentale aux États-Unis.
La société Cedar Clinical Research a mené 24 essais cliniques avec près de 1 100 patients, tandis que son programme de formation pour les praticiens a attiré presque 2 000 apprenants de 18 pays depuis mai 2024.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) hat seine fünf Wellness-Kliniken in den USA für 3,53 Millionen US-Dollar an Stella verkauft, was einen strategischen Wandel zu einem asset-light Geschäftsmodell darstellt. Der Deal umfasst eine Datenpartnerschaft zur Entwicklung KI-gestützter Klinikmanagementlösungen für Anbieter der psychischen Gesundheit.
Die Transaktionsbedingungen beinhalten 2,08 Millionen US-Dollar, die bei Abschluss gezahlt werden, 750.000 US-Dollar in monatlichen Raten bis 2025 und mögliche Earn-out-Zahlungen von bis zu 700.000 US-Dollar. Numinus wird seine Erfahrung mit 50.000 einzigartigen Individuen und 250.000 erstatteten Versicherungsansprüchen nutzen, um Lösungen für einen geschätzten Markt von 200.000 psychischen Gesundheitsanbietern in den USA zu entwickeln.
Die Cedar Clinical Research-Abteilung des Unternehmens hat 24 klinische Studien mit fast 1.100 Patienten durchgeführt, während das Schulungsprogramm für Fachkräfte seit Mai 2024 fast 2.000 Lernende aus 18 Ländern angezogen hat.
- None.
- None.
- Numinus Wellness clinics acquired by Stella for
US $3.53 million - Numinus focusing on business units and product development ("Numinus Network") to facilitate clinic efficiency and care reimbursement for mental health practitioners
- Stella partnering with Numinus to share operational data from its network of 12 mental health clinics, supporting the development of advanced clinic management solutions for mental health practices, including insurance reimbursement support
- Creates an asset-light business with a synergistic combination of clinical support, practitioner training and clinical research with a strengthened balance sheet
"Stella and Numinus are very much aligned in terms of standards of care and a focus on optimized patient outcomes," said Michael Gershenzon, Co-Founder and CEO of Stella. "Numinus patients can look forward to the same high levels of service that the clinics are known for and an expanded offering of behavioral care. We also look forward to working with Numinus to improve clinical mental health care nationwide."
"With this transaction, Numinus is re-positioning to leverage its expertise in patient care, clinic management, relationships with Insurers and now, significant access to operational data to assist clinical providers with the challenge to meet the demand of the growing number of patients seeking treatment," said Payton Nyquvest, Founder and CEO of Numinus.
Numinus is developing an AI-based SaaS solution leveraging its deep patient care expertise. This includes serving about 50,000 unique individuals, over 200,000 appointments, and generating about 250,000 insurance-reimbursed claims. The solution will redefine clinics' operations, from improving patient outcomes to optimizing efficiencies and reimbursement processes. The Company estimates a target market of over 200,000 mental health care providers in the
This new asset-light offering complements the Company's Cedar Clinical Research and practitioner training businesses. Cedar Clinical Research is the research partner of choice for leading drug development companies, including traditional pharmaceutical companies, research organizations, and psychedelic drug development companies. Year to date, Cedar Clinical has facilitated 24 clinical trials with almost 1,100 patients, accompanied by strong revenue growth. Numinus' practitioner training program leverages the Company's clinic-based treatment and clinical research expertise to offer a comprehensive training program. Major regulatory bodies accredit the program; since May 2024, it has attracted almost 2,000 learners from 18 countries.
"Getting to this point in our development would not have been possible without the skilled and caring therapists, medical professionals and clinic staff who have helped guide hundreds of patients on their mental health journey," added Mr. Nyquvest. "With our new offering, we look forward to helping practitioners across the
Details of the Agreement
Stella MSO LLC acquired Numinus Wellness' five
- Total consideration of
US paid at closing$2.08 million - Consideration of
US paid over six equal monthly instalments in 2025$750,000 - Earn-out compensation of up to
US to be paid in 2025$0.7 million - Stella is in the process of finalizing a partnership with Numinus, where Stella will provide operational data from its network of 12 mental health clinics
About Numinus
Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – technology-driven clinic support, clinical trial research and comprehensive practitioner training – is at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, and Instagram.
About Stella Mental Health:
Stella is an interventional psychiatry practice dedicated to delivering the most effective mental health protocols for severe trauma, stress, anxiety, depression, and post-traumatic stress injury (PTSI). With a team of board-certified physicians, advanced psychiatric nurse practitioners, psychologists, psychiatrists and advocates, Stella combines biology, psychology, and psychiatry to address the complex needs of patients. Stella has 20+ locations across
Partnership & Media Inquiries: Daphne Ortiz daphne.ortiz@stellacenter.com
Forward-looking statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements, including information regarding expectations regarding the potential benefits of the transaction and the ability of the company to successfully achieve business objectives; and expectations for other economic, business, and/or competitive factors, and other risks that are set forth in our annual information form dated November 29, 2023, and available on SEDAR at www.sedarplus.ca. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. Numinus does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/numinus-wellness-closes-sale-of-clinics-and-launches-initiative-to-increase-access-to-mental-health-care-302333195.html
SOURCE Numinus Wellness Inc.
FAQ
How much did Stella pay for Numinus Wellness's U.S. clinics in December 2024?
What is Numinus's new business strategy after selling its U.S. clinics?
How many clinical trials has Numinus's Cedar Clinical Research conducted?
What is the scope of Numinus's (NUMIF) patient care experience?
How many healthcare providers does Numinus aim to serve with its new platform?
